MREO
Mereo BioPharma
MREO
MREO
63 hedge funds and large institutions have $49.4M invested in Mereo BioPharma in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
23% less call options, than puts
Call options by funds: $162K | Put options by funds: $211K
31% less capital invested
Capital invested by funds: $71.8M → $49.4M (-$22.4M)
Holders
63
Holding in Top 10
–
Calls
$162K
Puts
$211K
Top Buyers
| 1 | +$774K | |
| 2 | +$538K | |
| 3 | +$475K | |
| 4 |
Alkeon Capital Management
New York
|
+$344K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$269K |
Top Sellers
| 1 | -$5.5M | |
| 2 | -$1.53M | |
| 3 | -$593K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$485K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$431K |